Update shared on11 Sep 2025
Fair value Increased 1.17%Following marginal improvements in IHI's net profit margin and revenue growth forecasts, analysts maintained effectively steady expectations, resulting in a slight upward revision of the consensus price target from ¥17,100 to ¥17,300.
What's in the News
- Board approved a 7-for-1 stock split and related amendment to the Articles of Incorporation.
- The total number of authorized shares will be revised effective October 1, 2025.
- Dividend forecast is under review following the stock split.
- Issued consolidated earnings guidance for FY ending March 31, 2026: revenue JPY 1,650,000 million, operating profit JPY 150,000 million, net profit JPY 120,000 million, EPS JPY 112.85.
Valuation Changes
Summary of Valuation Changes for IHI
- The Consensus Analyst Price Target remained effectively unchanged, moving only marginally from ¥17100 to ¥17300.
- The Net Profit Margin for IHI remained effectively unchanged, moving only marginally from 7.73% to 7.88%.
- The Consensus Revenue Growth forecasts for IHI remained effectively unchanged, moving only marginally from 4.9% per annum to 5.0% per annum.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.